Tebentafusp trials for Melanoma

All Tebentafusp trials · All Melanoma trials

Phase breakdown

Recruiting trials studying Tebentafusp for Melanoma

• Adjuvant Tebentafusp in High Risk Ocular Melanoma
  NCT06246149 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
  NCT07057596 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
  NCT07276386 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
  NCT06627244 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
  NCT05549297 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 82 locations
• Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
  NCT06070012 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

How many trials study Tebentafusp for Melanoma?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.